Essential Pharma and International Health Partners Collaborate to Provide Life-Saving Medicines to Vulnerable CommunitiesEssential Pharma and International Health Partners Collaborate to Provide Life-Saving Medicines to Vulnerable Communities Egham, UK – July 10, 2024 – Essential Pharma, a leading international specialty pharmaceutical group committed to patient access to essential medicines, has partnered with International Health Partners (IHP), a global health NGO dedicated to improving healthcare access in disaster-hit and vulnerable communities. Together, they aim to donate essential medicines to over 30,000 patients worldwide. Essential Medicines Provided Essential Pharma’s donation includes antibiotics, cardiovascular medications, and mental health treatments. These medicines will support IHP’s signature programs in disaster relief, mental health, and non-communicable diseases. Addressing Unmet Needs Lily Jones-Herbst, Manager Corporate Partnerships at IHP, emphasized the critical need for these essential medicines: “This donation will make a life-saving difference to patients who would otherwise struggle to access the medicines they need.” Reducing Medicine Waste Emma Johnson, CEO of Essential Pharma, highlighted the environmental benefits of the partnership: “Not only are we helping global communities, but we are also reducing medicine waste, aligning with our ESG commitments.” About Essential Pharma Essential Pharma specializes in preserving access to clinically differentiated Niche medicines for small patient populations. The group operates in over 70 countries, with a focus on central nervous system (CNS), gastroenterology, ophthalmology, and rare diseases. About International Health Partners IHP coordinates the donation of quality medical supplies to support disaster response, long-term health development projects, and healthcare professionals worldwide. It responds rapidly to humanitarian crises and works to eradicate the suffering caused by lack of healthcare access. Contacts Essential Pharma: Emma Johnson, CEO +44(0)1784 477 167 [email protected] ICR Consultant: Tracy Cheung/Chris Welsh/Isabelle Abdou +44 (0) 20 3709 5700 [email protected] International Health Partners (IHP): Lily Jones-Herbst, Corporate Partnerships Manager +44 020 3735 5489 [email protected]
Essential Pharma launches campaign with international health partners to donate life-saving medicines to disaster-hit countries
Donations to support over 30,000 patients in disaster-affected and vulnerable communities worldwide while reducing medicine waste
Antibiotics, cardiovascular and mental health medicines are covered by International Health Partners’ (IHPs) signature programs, maximizing patient impact
Egham, UK – July 10, 2024 – Essential Pharma, an international specialty pharmaceutical group focused on ensuring sustainable patient access to low-volume, clinically differentiated niche pharmaceutical products in key therapeutic areas, today launches a campaign with International Health Partners (IHP), a global health NGO committed to improving access to healthcare for people in disaster-affected and vulnerable communities, to donate essential medicines to over 30,000 patients.
IHP enables better access to healthcare around the world by facilitating and delivering the donation of essential medicines to those who need them most, with expertise in quality management, warehousing and logistics. Essential Pharma’s medicine donations include antibiotics and treatments for cardiovascular and mental health conditions. They will help strengthen vulnerable and disaster-affected health systems and ensure that communities have access to a wide range of medicines, free at the point of use. In support of IHP’s signature programmes in disaster relief, mental health and non-communicable diseases, the donation of antibiotics and treatments for cardiovascular and mental health conditions is critical to meeting these growing health needs.
Lily Jones-Herbst, Manager Corporate Partnerships at International Health Partners, comment given: “We are so grateful for Essential Pharma’s generous donation of medicines, which will make a life-saving difference to patients around the world who would otherwise struggle to access the medicines they need. These contributions are vital to our rapid disaster response, the sustainability of long-term health programmes and the consistent availability of our Essential Health Packs, which deliver critical primary care in every setting. On behalf of all of us at IHP, I thank Essential Pharma for this substantial donation, which will play a vital role in improving health outcomes for thousands of patients worldwide.”
“Today we are extremely proud to announce our partnership with IHP, which will facilitate the delivery of these life-saving medicines to the patients who need them most. Billions of pounds of usable medical supplies are lost every year. By working with IHP, we are not only helping global communities, but also reducing medicine waste and our impact on the environment, in line with our ESG commitments,” said Emma Johnson, CEO of Essential Pharma“This partnership enables Essential Pharma to leverage IHP’s connections in vulnerable and disaster-affected regions to address the persistent problem of access to medical supplies. With these donations of essential medicines, we are doing our part to bridge the gap and we look forward to many more.”
About Essential Pharma
Essential Pharma is an international specialty pharmaceutical group focused on preserving access to clinically differentiated, niche medicines in small patient populations. The Group has been a key and valued partner to healthcare providers for over 20 years, helping underserved patient populations access medicines that may otherwise be unavailable and addressing unmet clinical needs. Essential Pharma operates in over 70 countries worldwide, delivering a portfolio of products with a focus on central nervous system (CNS), gastroenterology, ophthalmology and rare diseases. The Group’s growth strategy focuses on portfolio optimization and a targeted M&A approach to acquire commercial and late-clinical assets across its four therapeutic areas of focus. It is a trusted partner to pharmaceutical companies of all sizes, with a proven track record of integrating assets and seamlessly managing complex technology transfers, while ensuring continuous and sustainable supply to patients.
Essential Pharma is backed by Gyrus Capital, an investment firm focused on transformative investments in sectors with sustainable long-term growth, including healthcare.
For more information, please visit www.essentialpharmagroup.com
About International Health Partners
International Health Partners (IHP) is a global health NGO dedicated to improving access to health care for people in disaster-affected and vulnerable communities by coordinating the safe and responsible donation of long-term, quality medical supplies. Together with its strong network of global health partners, it procures and ships medicines to support people around the world. It responds rapidly to humanitarian disasters, supports long-term health development projects, and provides clinicians with the supplies they need to do their jobs. IHP bridges the gap between healthcare companies and humanitarian organizations, helping individuals and communities access the essential medicines and health supplies they need. Its vision is to see a world where all suffering due to lack of health care is eradicated.
For more information, visit www.ihpuk.org
CONTACTS
Essential pharmacy
Emma Johnson, CEO
Phone: +44(0)1784 477 167
Email address: [email protected]
ICR Consultant
Tracy Cheung/Chris Welsh/Isabelle Abdou
Phone: +44 (0) 20 3709 5700
Email address: [email protected]
International Health Partners (IHP)
Lily Jones-Herbst, Corporate Partnerships Manager
Phone: +44 020 3735 5489
Email address: [email protected]
